Pfizer signs deal with Allogene to develop cancer cell therapy – KFGO
KFGO |
Pfizer signs deal with Allogene to develop cancer cell therapy
KFGO (Reuters) – Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy. The agreement will … |
